The company
Quoin Pharmaceuticals, Ltd. - American Depositary Shares
QNRX · Nasdaq
QNRX stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 40 weeks. It is 29.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 40
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $560K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 19 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Anthony James CulverwellDirector | bought | 6,146at $4.88 | 31 Aug 2026filed 1 Sep 2026 |
| Anthony James CulverwellDirector | bought | 3,073 | 31 Aug 2026filed 1 Sep 2026 |
| Sally Bridget LawlorChief Financial Officer | bought | 10,244at $4.88 | 31 Aug 2026filed 1 Sep 2026 |
| Sally Bridget LawlorChief Financial Officer | bought | 5,122 | 31 Aug 2026filed 1 Sep 2026 |
| Michael MyersChief Executive Officer | bought | 20,490at $4.88 | 31 Aug 2026filed 1 Sep 2026 |
| Michael MyersChief Executive Officer | bought | 10,245 | 31 Aug 2026filed 1 Sep 2026 |
| Denise P. CarterChief Operating Officer | bought | 20,490at $4.88 | 31 Aug 2026filed 1 Sep 2026 |
| Denise P. CarterChief Operating Officer | bought | 10,245 | 31 Aug 2026filed 1 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Stonepine Capital Management, LLCadded · filed 14 Aug 2026 | 765,546$2.0M | +712,086+1332.0% |
| Dauntless Investment Group, LLCadded · filed 13 Aug 2026 | 214,987$1.0M | +18,395+9.4% |
| Ikarian Capital, LLCunchanged · filed 14 Aug 2026 | 211,538$1.0M | 00.0% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 112,323$544K | +36,076+47.3% |
| SummitTX Capital, L.P.unchanged · filed 14 Aug 2026 | 100,300$485K | 00.0% |
| Woodline Partners LPreduced · filed 14 Aug 2026 | 76,446$370K | -3,136−3.9% |
| Aberdeen Group plcunchanged · filed 31 Jul 2026 | 75,000$363K | 00.0% |
| Soleus Capital Management, L.P.unchanged · filed 11 Aug 2026 | 72,730$352K | 00.0% |
| AIGH Capital Management LLCadded · filed 7 Aug 2026 | 70,000$339K | +19,000+37.3% |
| BOOTHBAY FUND MANAGEMENT, LLCunchanged · filed 14 Aug 2026 | 59,838$290K | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.